Clinical Trial Update: Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease [Phase 4]

View source ↗

Summary

Phase 4 study evaluating Acthar Gel delivered via a single-dose pre-filled SelfJect injector in patients with autoimmune diseases and keratitis, including dry e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Dry Eye Disease
• Neurotrophic Keratitis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Toyos Clinic | Conditions: Autoimmune Diseases, Dry Eye | Phase 4 | Status: RECRUITING